News
5 Trends In Medical And Orthopedic Devices
Orthopedic devices are a significant part of improving the health of patients with musculoskeletal conditions or those affecting the joints, bones, tendons, ligaments, and muscles. Due to recent technological advancements, there’s been a notable improvement in the devices used...
IT & Data Management
MaineHealth Turned COVID-19 Award Into Telehealth Scheme
Similar to several other health systems around the nation, COVID-19 forced MaineHealth to act quickly to care for patients remotely in order to protect both individuals and care teams.
The Issue
According to Lizzy Mulcahy, director of telehealth at the Portland,...
News
Everything You Need to Know about Aqualyx Injections
If you've ever felt like the results of all your dieting and exercising are not satisfactory, you may have stubborn fat deposits that cannot be eliminated through diet and exercise alone. Of course, we know where they are, those...
News
Top Reasons for Failing to Report Test Results to a Patient
There are many reasons a healthcare professional might fail to report test results to a patient. Sometimes, the doctor or nurse might not realize they are supposed to report the results. Other times, they may forget or believe that...
Drug Research
Three Pharma MSMEs Programmes Launched By Indian Government
Three programmes were introduced by the Indian government on July 21st to support Micro, Small and Medium-Sized Enterprises (MSMEs) in the pharmaceutical industry. At the launch event, Mansukh Mandaviya, the Union Minister, said that the programmes call for the establishment...
Drug Research
Universal Coronavirus Monoclonal Therapy For COVID-19 Strain
Since 2019, the SARS-CoV-2 that produces COVID-19 has tragically highlighted the fragility of humanity to new coronaviruses by killing 6.3 million people globally.
In order to combat SARS-CoV-2 and all of its potentially dangerous variations, namely Beta, Gamma, Delta, Epsilon,...
Drug Research
FDA Examines 2 Other Cancer Approvals Without Revocation
The oncology division of the FDA has recently tightened regulations for expedited approvals and emphasised the significance of patient survival data. Several businesses promptly followed suit and withdrew questionable indicators when the agency applied more pressure. However, some businesses...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read